Juul Labs Inc.

Juul Labs, Inc., commonly known as Juul, is an American electronic cigarette company. Originally founded as Ploom Inc. in 2007 and later operating as Pax Labs, the company officially spun off as Juul Labs, Inc. in 2017. While some sources indicate a San Francisco base, its corporate office is currently headquartered in Washington, D.C., and it operates as a privately held company. Until 2023, Altria Group held a 35% stake in Juul, which it later divested, exchanging its shares for an interest in Juul's heated tobacco intellectual property. The company employs hundreds of individuals, with estimates ranging from approximately 420 to over 1,100, and reported revenue of around $2 billion in 2018, with more recent estimates at $408.9 million annually.

Juul Labs manufactures and sells vaporizer devices and nicotine-containing pods, often referred to as e-cigarettes. Its flagship product is the Juul electronic cigarette, designed to atomize nicotine salts for adult smokers as an alternative to combustible cigarettes. The company's products include closed and open system vaping devices. Juul Labs states its mission is to transition adult smokers away from traditional cigarettes while combating underage use of its products.

In terms of patent litigation, Juul Labs operates as an active litigant, primarily asserting its intellectual property rights against competitors rather than solely defending against non-practicing entities. The company's sole tracked case shows it as a plaintiff in the U.S. International Trade Commission (ITC), a venue often sought for its ability to issue import bans. This aligns with a posture of an operating company aggressively protecting its patented technology.

The tracked case, Juul Labs Inc. v. Altria et al., filed in the ITC in 2025, is part of an ongoing and multi-faceted patent dispute between Juul Labs and Altria, particularly concerning Altria's NJOY e-vapor products. Juul Labs has initiated multiple ITC actions against NJOY (an Altria subsidiary) for alleged patent infringement, successfully securing orders prohibiting the importation and sale of infringing NJOY ACE products. Conversely, Altria had also filed patent infringement actions against Juul Labs in the ITC, which were terminated, with the ITC finding that Juul Labs did not infringe Altria's asserted patents. This demonstrates Juul Labs' consistent strategy of enforcing its patent portfolio to protect its market position.